Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC)
is lobectomy with mediastinal lymph node dissection or sampling. Stereotactic ablative …

Most new radiation techniques, have been introduced primarily to reduce the dose to normal
tissues in order to prevent radiation-induced side effects. Radiotherapy with protons is such …

Background The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and
neck (MARCH) showed that altered fractionation radiotherapy is associated with improved …

Background The COVID-19 pandemic has caused radiotherapy resource pressures and led
to increased risks for lung cancer patients and healthcare staff. An international group of …

Background A phase III multi-centre randomised trial (ROSEL) has been initiated to establish
the role of stereotactic radiotherapy in patients with operable stage IA lung cancer. Due to …

Humans are continuously exposed to polymeric materials such as in textiles, car tires and
packaging. Unfortunately, their break down products pollute our environment, leading to …

Stereotactic body radiotherapy (SBRT) for patients with metastatic cancer, especially when
characterised by a low tumour burden (ie, oligometastatic disease), receiving targeted …

Background and purpose Stereotactic ablative radiotherapy (SABR; or stereotactic body
radiotherapy, SBRT) emerges as treatment option for pulmonary oligometastatic disease (OMD)…

Purpose: In recent years several papers have been published on radiation-induced cardiac
toxicity, especially in breast cancer patients. However, in esophageal cancer patients the …

Purpose Reducing dose to normal tissues is the advantage of protons versus photons. We
aimed to describe a method for translating this reduction into a clinically relevant benefit. …